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T’he function of the positively charged C-terminal region of mitochondrially encoded subunit 8 of yeast mitochondrial ATP synthase was investigat- 
ed using derivatives truncated at each of the 3 positively charged residues (A@‘, Arti* and Lys”). Each construct, allotopically expressed in the 
nucleus, was tested for its ability to import and assemble functionally into ATP synthase in yeast cells unable to synthesize mitochondrial subunit 
8. The efficiency of import of each construct into isolated wild-type yeast mitochondria was also determined. One construct runcated at the penulti- 
mate residue of subunit 8 (Lys *‘) functions in vivo and shows efficient import in vitro. Thus subunit 8 can function with only two positively charged 
residues. The remainder of the subunit 8 variants failed to rescue in vivo. Since they all show greatly reduced or undetectable import in vitro, 
presumably because of the increased hydrophobic character of the subunit 8 moiety in the chimaeric precursors, the status of these variants as 
regards assembly and function is not clear. 
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1. INTRODUCTION 
Subunit 8 (Y8) is one of the 3 hydrophobic subunits 
in the membrane-embedded F, sector of the yeast 
mitochondrial proton-translocating ATP synthase 
(mtATPase). This subunit is characterized by a relative- 
ly short length of 48 residues. It contains a central non- 
polar region representing a single transmembrane stem 
and a polar C-terminus with 3 positively charged 
residues [1,2]. This polar tail probably lies on the matrix 
side of the inner membrane [3]. Intensive investigations 
in Saccharomyces cerevisiae have shown that Y8, a pro- 
duct of the mitochondrial aapl gene, is critical for the 
assembly of a functional F, sector [4,5]. The other two 
hydrophobic components of the F, sector, subunits 6 
and 9, contain transmembrane helices with charged 
amino acids thought to be directly involved in proton 
conductivity across the membrane [l]. 
The approach we have adopted for studying the 
structure and function of mitochondrially encoded pro- 
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teins is denoted allotopic expression [a]. This entails 
relocating an organellar gene to the nucleus and redirec- 
ting the encoded protein back to the organelle. In the 
case of Y8, an artificial gene has been made which en- 
codes a chimaeric protein consisting of the N-terminal 
leader peptide of 66 amino acids (N9L) from mtATPase 
subunit 9 of Neurospora crassa, the first 5 amino acids 
of mature N. crassa subunit 9, 2 additional serine 
residues resulting from the DNA sequence at the fusion 
point, and the 48 amino acids of Y8 (Fig. 1A). This 
chimaeric protein, denoted N9L/Y8-1 [7], is imported 
into yeast mitochondria both in vivo [l] and in vitro [8], 
where it is processed at the natural cleavage point of N. 
crassa subunit 9 [9]. The imported, processed Y8 is 
assembled functionally into mtATPase in vivo; this is 
observed when N9L/Y8-1 is allotopically expressed in 
aapl mit- cells which are incapable of synthesizing Y8 
inside mitochondria [ 11, A derivative construct, 
denoted N9L/Y8-2 (Fig. lB), in which the super- 
numerary 7 amino acids interposed between the N9L 
leader and the mature Y8 moiety have been removed by 
site directed mutagenesis [7], can be imported into 
mitochondrial in vitro [7] and functions in vivo much 
like its N9L/Y8-1 parent [2]. 
The allotopic expression strategy therefore provides a 
means of systematically analyzing structure-function 
aspects of Y8. This communication focuses on the 
charged hydrophilic tail towards the carboxy terminus 
of the protein. A series of mutants has been constructed 
in vitro, in which Y8 is prematurely terminated at each 
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of the 3 positively charged amino acids found in this 
region. These variant constructs were examined for 
their ability to rescue an aapl mit- host in vivo and to 
be imported into wild-type mitochondria in vitro. The 
data show that the most distal charged residue (Lys4’) is 
dispensable for the function of YS. All other truncated 
constructs studied here failed to rescue aapl mit - cells 
in vivo. With one exception, these non-rescuing 
variants were unable to be imported in vitro, so that 
detailed assessment of their function in vivo could not 
be made. 
2. MATERIALS AND METHODS 
2.1, In vitro mutagenesis 
Most of the mutants were generated in recombinant bacteriophage 
Ml3mpl8 using the BioRad MutaGene in vitro mutagenesis kit. Two 
of the mutants, N9L/Y8-1 (R37-STP) and N9L/YS-2(R37STP), were 
generated in the phagemid construct pMTl7 [lo]. The oligonucleo- 
tides used for each mutagenesis changed the codon encoding the rele- 
vant charged amino acid to TAA, and had 8 bases on either side of 
the mutation homologous to the artificial gene encoding Y8 [1 11. In 
general, cassettes of mutaged genes, flanked by BamHl sites, were 
transferred to pUCl8 for propagation. For expression in vivo and in 
vitro, the mutant genes were transferred to vectors pLF1 [l] and 
pSP64T [ 121, respectively. 
2.2. DNA sequence confirmation 
The sequence of the mutant alleles following recloning in each of 
the vectors was confirmed by DNA sequencing following amplifica- 
tion by an asymmetric polymerase chain reaction (PRC) procedure. 
DNA of purified plasmids, or extracts of bacterial or yeast cells in 
which the plasmids are propagated, were diluted to give a sample of 
approximately 5 amol vector, which was then used to generate single- 
stranded sequencing template by asymmetric PCR (131. The reaction 
used 50 pmol of a forward primer (5’CCACCAGTAGAGACATG- 
GG3’) for pLF1 or (5lGGCTGGTTTAGTGGTAAC3’) for 
pSP64T, close to the 3 ’ end of the Y8 sequence in the respective vector 
DNA, and 0.5 pmol of a reverse primer (5’GGATCCATGGCCTC- 
CACTCGTGTCCT3 ‘), within the 5 ’ end of the N9L leader se- 
‘quence. After purification by phenol:chloroform extraction (1: 1) and 
ethanol precipitation in the presence of 2.5 M ammonium acetate, a 
sample of the asymmetric PCR products was directly sequenced with 
an internal sequencing primer (5’AGATGACCTCCATCGTCAAC- 
3 ‘), located in the N9L leader sequence near the junction with the Y8 
sequence, using the T7 dideoxy sequencing kit of Pharmacia. 
2.3. Strains and genetic analyses 
Saccharomyces cerevisiae strain J69-1B [rho’), the derived aapl 
mit- strain M31, and growth media for genetic analyses are as 
described [l]. The yeast expression vector pLF1 was used to express 
variant N9L/Y8 constructs in the mit- strain M31. Where rescue was 
observed (i.e. acquisition by transformant M31 cells of the ability to 
grow on ethanol), confirmation was obtained concerning the plasmid 
dependence of the rescued phenotype by genetic analysis, as described 
[ll. 
2.4. Import into isolated mitochondria 
Using “S-labelled variant constructs expressed by transcription and 
translation in vitro [14], import experiments were carried out in vitro 
with mitochondria isolated from yeast strain J69-lB, as described 
D51. 
3. RESULTS 
3.1. Nature of subunit 8 truncation mutants 
The series of truncation mutants we have prepared is 
shown in Fig. 1. Two sets of variants were made, star- 
N9l./YEl(R42STP) 
NwY9-1(Fl37-STP) 
+ + +++ Y * + I+ - 
B N9lN9-2 
++ l ++ * * + * + l + 
NOLIYE2(K47-STP) 
+* +++ * * + a+ + + 
N9L/YE2@42-STP) 
++ +++ +I. * + * + 
NOL/YG2(R37-STP) 
Fig. 1. Chimaeric fusion proteins and truncated derivatives used for 
allotopic expression. The truncated sets are based on the parent 
constructs N9L/Y8-1 (A) and N9L/YS-2 (B) detailed in the text 17). 
The nomenclature K47-STP, R42-STP and R37-STP, indicates that 
the codon for the designated amino acid has been converted to the 
TAA stop codon. The distribution of charged amino acids 
throughout each chimaeric polypeptide is indicated. Hatched blocks, 
N9L; solid blocks, Y8. In N9L/Y8-1 a 7 residue block is interposed 
[8] between N9L and Y8 (see text). 
ting with constructs encoding either N9L/Y8-1 or 
N9L/Y8-2 [7], which differ in the junction between the 
N9L and Y8 sequences (Fig. 1). In each case a codon 
specifying one of the 3 positively charged residues in the 
C-terminal tail, Lys4’, Arg4* and Arg3’, was converted 
to the termination codon TAA. It is convenient to 
describe separately for each of two sets of constructs 
based on either N9L/Y8-1 or N9L/Y8-2, the results ob- 
tained in both in vivo functional tests and in vitro im- 
port assays. 
3.2. The N9L/Y8-I series 
The N9L/Y8-l(K47-STP) chimaeric protein does 
restore function to the mtATPase in vivo (Table I), as 
its allotopic expression in strain M31 confers on 
transformed cells the ability to grow on ethanol. The 
most distal positive charge (Lys4’ in Y8 is thus dispen- 
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Table I 
Properties of allotopically expressed variants of yeast mitochondrial 























Behaviour of Y8 variants based on parent constructs N9L/Y8-1 and 
Iy9L/YS-2 (Fig. 1) is indicated for rescue experiments (restoration of 
growth on ethanol following in vivo expression of construct in aupl 
mit - strain M3 1) and import experiments (ability of precursor to be 
imported and processed in isolated mitochondria; Fig. 2). 
sable in terms of the assembly and function of the yeast 
mtATPase. Whilst transformed M3 1 cells expressing 
N9L/Y8-l(K47-STP) show slower growth rates in liq- 
uid medium containing ethanol compared to those of 
J69-1B (data not shown), it is clear that Y8 can function 
with only the two positively charged residues Arg42 and 
Arg3’ at its C-terminus. 
Any further truncation of the N9L/Y8-1 construct at 
positively charged residues in Y8 beyond Lys4’ (Fig. 1) 
prevents the chimaeric protein from restoring the func- 
tion of the mtATPase, since no rescue of strain M31 
was observed (Table I). In principle, such behaviour 
could be due to an impediment at one of several evels, 
for example: import of the chimaeric protein into 
mitochondria; assembly of the imported protein into 
mtATPase; or function of the enzyme complex contain- 
ing the assembled protein. When these chimaeric pro- 
A. N9UY8-1 K47-STP R42STP R37-STP 
teins are further examined for their ability to be im- 
ported into mitochondria in vitro (Fig. 2A), a super- 
ficial correlation is found between in vivo rescue and in 
vitro import competence. Efficient import is seen with 
N9L/Y8-l(K47-STP), as evidenced by the production 
of a processed product close to the size of Y8 (lane 4), 
as occurs with the parent construct N9L/Y8-1 (lane 2). 
Note that import does not occur for either of the other 
truncated proteins based on N9L/Y8-1 (lanes 6 and 8); 
the data are summarized in Table I. It is thus not possi- 
ble to define, from these results, the behaviour of the 
truncated derivatives R42-STP or R37-STP in assembly 
or function of mtATPase. 
3.3. The N9L/Y8-2 series 
The N9L/Y8-2 set of truncated proteins (Fig. 1B) are 
constructed to parallel the N9L/Y8-1 set, except hat in 
each case the N9L leader directly abuts the Y8 sequence. 
In vivo rescue occurs with full length N9L/Y8-2 (Table 
I). The less efficient in vitro import of N9L/Y8-2 (Fig. 
2B, lane 2) compared to that of N9L/Y8-1 (Fig. 2A) has 
now been repeatedly observed [16]. This indicates that 
the previously published data on in vitro import of 
N9L/Y8-2, in which comparable efficiencies were 
reported [7], was not a fully representative xample. 
This differential import efficiency suggests that the 7 
amino acids interposed between N9L and Y8 in 
N9L/Y8-1, but missing from N9L/Y8-2 (Fig. l), do 
play a role in facilitating the relatively efficient import 
of N9L/Y8-1. The first 5 of these amino acids represent 
the N-terminus of mature subunit 9 of N. crassa, and 
they may thus be important for the efficient import and 
1 2 3 4 5 6 7 8 
B. N9 W8-2 K47-STP R42-STP R37-STP 
1 2 3 4 5 6 7 8 
Fig. 2. In vitro import experiments on truncated derivatives of subunit 8. Radiolabelled fusion proteins (Fig. 1) based on parent constructs 
N9L/Y8-1 (A) and N9L/Y8-2 (B) were incubated with wild-type mitochondria under active import conditions [ 151. Odd and even numbered lanes 
refer to samples of the import mix taken after 0 and 30 min, respectively, and represent autoradiograms of proteins separated by SDS- 
polyacrylamide gel electrophoresis. Arrows indicate the position of the YS standard for each pair of lanes. 
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processing of this hydrophogic protein directed by its 
natural leader (N9L). Their precise role is not 
understood; for example, it is not clear if the negatively 
charged glutamic acid in this short block of residues is 
important in precursor conformation. 
Weak import in vitro of N9L/Y8-2(K47-STP) is evi- 
dent (Fig. 2B), but the more extensively truncated 
variants R37-STP and R42-STP show no detectable im- 
port. The significantly reduced import of, 
N9L/Y8-2(K47-STP) (Fig. 2B, lane 4) in comparison to 
that of its N9L/Y8-1 counterpart (Fig. 2A, lane 4) is 
demonstrated by the relatively high ratio of precursor 
to processed product remaining after an import reac- 
tion incubation period of 30 min. This parallels the 
decreased efficiency of in vitro import noted for full- 
length N9L/Y8-2 compared to N9L/Y8-1 (see above), 
thus reemphasizing the facilitative role of the 7 amino 
acids interposed betwen N9L and Y8 in precursor im- 
port. 
Tests of in vivo rescue of aapl mit- cells show that 
none of the truncated N9L/Y8-2 derivatives is able to 
restore mtATPase activity. The failure of 
N9L/Y8-2(K47-STP) to rescue strain M3 1 may either 
be due to the non-assembly of the imported protein or, 
if assembled, its inability to function. It is also not yet 
possible to define assembly and functional properties of 
the more extensively truncated N9L/Y8-2 derivatives. 
4. DISCUSSION 
A series of truncated variants of Y8 expressed 
allotopically has been studied in order to define the role 
of the positively charged C-terminal tail of Y8. The data 
obtained show the dispensability of the most distal 
charged residue (LYs~~) for the function of Y8. Conclu- 
sions concerning the assembly and functional properties 
of the shorter Y8 derivatives are, however, difficult to 
make in view of the impaired import properties of these 
truncated variants. Detailed information on the in vivo 
import and assembly behaviour of the truncated 
variants is required to evaluate the impediment to 
restoration of function in each case. 
Why do these C-terminally truncated variants of Y8 
show such inefficient import in vitro? The positively 
charged amino acids in the tail of Y8 evidently make an 
important contribution to the overall conformation of 
the chimaeric precursor (N9L/Y8-1 or N9L/Y8-2) in 
relation to its presentation to the import apparatus. The 
special role of protein conformation in the importation 
of precursors containing hydrophobic domains (such as 
N9L/Y8-1) has been emphasized by recent studies in 
this laboratory [17]. Thus the import capability of 
N9L/Y8-1 is abolished after pretreatment with 4 M 
urea, which is thought to unfold this precursor. 
Moreover, after urea-pretreatment N9L/Y8-1 binds 
avidly to the mitochondria, presumably by hydropho- 
bic interactions with the membrane [171. Clearly there is 
a delicate balance between unfolding, productive bin- 
ding and non-productive binding, that must be main- 
tained by the import system in dealing with precursors 
containing very hydrophobic domains. 
Against this background, we can consider possible 
explanations of why the removal of the positive charges 
from the C-terminus of N9L/Y8-1 or N9L/Y8-2 
renders the precursor non-importable. As successive 
truncations are introduced, the passenger protein join- 
ed to the N9L leader becomes increasingly 
hydrophobic. One reason for the failure of these trun- 
cated Y8 variants to be imported could be that the now 
very hydrophobic passenger moiety embeds into the 
mitochondrial outer membrane, leading to a similar 
non-productive binding as is observed following urea- 
pretreatment of N9L/Y8-1 [17]. Another possibility is 
that the precursor may now be maintained in a tightly 
folded conformation in which the leader peptide is not 
available to interact with the import apparatus as a key 
step in the import process [18]. In the latter case, one 
could imagine that the C-terminal positive charges on 
the chimaeric precursors containing full-length Y8 are 
electrostatically repulsive to those on the N9L leader 
(Fig. l), and so help the precursor maintain an ‘open’ 
configuration. As the charged residues in Y8 are remov- 
ed by truncation, the increasingly hydrophobic 
passenger moiety could interact with the non-polar face 
of the amphipathic N9L leader sequence [19], thus 
‘closing up’ the molecular configuration of the precur- 
sor and limiting import. 
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